Patents by Inventor Akio Hayashi
Akio Hayashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8658132Abstract: A method for producing a radioactive diagnostic imaging agent containing a radioactive 18 fluorine-labeled organic compound represented by the following formula (1): as an effective ingredient in which radiolysis of the effective ingredient is inhibited, involves providing a solution containing the radioactive 18fluorine-labeled organic compound represented by the above formula (1), adding an acid to the solution obtained in the first step in an amount sufficient for the solution to be kept within a pH of 2.0-5.9 in the following third step, and diluting the solution obtained in the second step in order to adjust the solution to a desired radioactive concentration within a pH of 2.0-5.9.Type: GrantFiled: August 2, 2012Date of Patent: February 25, 2014Assignee: Nihon Medi-Physics Co., Ltd.Inventors: Daisaku Nakamura, Soichi Nakamura, Masahito Toyama, Akio Hayashi
-
Patent number: 8563771Abstract: A process is provided for producing a labeled precursor which is useful for production of a radioactive fluorine-labeled amino acid compound. In the reaction step for introducing a leaving group to a mixture of syn-form and anti-form of FACBC, a base is allowed to present in the reaction system to produce a syn-leaving group adduct, which is unreactive with the base and is highly stable, and an anti-leaving group adduct which can react with the base to form a water-soluble compound. By employing a purification method utilizing such a difference in solubility, the syn-leaving group adduct can be separated selectively. The base may be a linear- or branched-chain primary to tertiary alkylamine having 1 to 10 carbon atoms, a nitrogen-containing heterocyclic compound with 2 to 20 carbon atoms, and a nitrogen-containing hetero aromatic compound with 2 to 20 carbon atoms.Type: GrantFiled: December 17, 2007Date of Patent: October 22, 2013Assignee: Nihon Medi-Physics Co., Ltd.Inventors: Masahito Toyama, Akio Hayashi
-
Patent number: 8460886Abstract: A purpose of the present invention is to provide a method capable of more effectively prescribing an anti-human PD-1 antibody for anti-cancer therapy, a method for estimating or optimizing therapeutic efficacy thereof, and further an efficacy marker that can be used in methods thereof. The present invention enables selection of the cancer patient in whom the therapeutic efficacy of the anti-human PD-1 antibody can be expected in future, by measuring the change which is more than a certain level of several kinds of efficacy markers in blood, after administering the initial dose or doses of the anti-human PD-1 antibody compared to that prior to administering the initial dose, and provides a new prescription of the anti-human PD-1 antibody for anti-cancer therapy.Type: GrantFiled: July 3, 2009Date of Patent: June 11, 2013Assignees: Ono Pharmaceutical Co., Ltd., Medarex, Inc.Inventors: Shiro Shibayama, Takao Yoshida, Tamon Hayashi, Akio Hayashi, Jun Murai
-
Patent number: 8343459Abstract: A method for producing a radioactive diagnostic imaging agent which contains a radioactive halogen-labeled amino acid compound as an effective ingredient and has a composition that can inhibit radiolysis of the effective ingredient, thereby further improving stability, is provided. Disclosed is a method for producing a radioactive diagnostic imaging agent, comprising a solution preparation step of preparing a solution containing a radioactive halogen-labeled amino acid compound, and a dilution step of diluting the solution containing the radioactive fluorine-labeled organic compound in order to adjust radioactive concentration thereof, which further comprises an acid addition step of adding an acid to the solution containing the radioactive fluorine-labeled organic compound, after the solution preparation step and before the dilution step, wherein the acid is added in the acid addition step in an amount sufficient to adjust the pH of the solution resulting from the dilution step to 2.0-5.Type: GrantFiled: February 12, 2008Date of Patent: January 1, 2013Assignee: Nihon Medi-Physics Co., Ltd.Inventors: Daisaku Nakamura, Soichi Nakamura, Masahito Toyama, Akio Hayashi
-
Publication number: 20120301399Abstract: A method for producing a radioactive diagnostic imaging agent containing a radioactive 18 fluorine-labeled organic compound represented by the following formula (1): as an effective ingredient in which radiolysis of the effective ingredient is inhibited, involves providing a solution containing the radioactive 18fluorine-labeled organic compound represented by the above formula (1), adding an acid to the solution obtained in the first step in an amount sufficient for the solution to be kept within a pH of 2.0-5.9 in the following third step, and diluting the solution obtained in the second step in order to adjust the solution to a desired radioactive concentration within a pH of 2.0-5.9.Type: ApplicationFiled: August 2, 2012Publication date: November 29, 2012Applicant: NIHON MEDI-PHYSICS CO., LTD.Inventors: Daisaku NAKAMURA, Soichi Nakamura, Masahito Toyama, Akio Hayashi
-
Patent number: 8277777Abstract: A compound that has affinity with amyloid, exhibits sufficiently rapid clearance from normal tissues, and is suppressed in toxicity such as mutagenicity is provided, which is represented by the following formula (1): or a salt thereof, wherein R1 is a group selected from hydrogen, hydroxyl group, carboxyl group, sulfate group, amino group, nitro group, cyano group, an alkyl substituent with one to 4 carbon atoms or an alkoxy substituent with one to 4 carbon atoms; R2 is a radioactive halogen substituent; and m is an integer of 0 to 2, and a low-toxic diagnostic agent for Alzheimer's disease comprising a compound represented by the above formula or a salt thereof is also provided.Type: GrantFiled: June 21, 2007Date of Patent: October 2, 2012Assignees: Nihon Medi-Physics Co., Ltd., GE Healthcare LimitedInventors: Shigeyuki Tanifuji, Akio Hayashi, Daisaku Nakamura, Shinya Takasaki, Anthony Eamon Storey, Denis Raymond Christophe Bouvet
-
Patent number: 8269035Abstract: A process for production of a radioactive fluorine-labeled organic compound is provided which can improve the yield of radioactive fluorination. Provided is a process in which a compound represented by the following formula (1): (wherein R1 is a straight or branched alkyl chain with 1-10 carbon atoms or an aromatic substituent, R2 is a straight or branched haloalkylsulfonic acid substituent with 1-10 carbon atoms, a straight or branched alkylsulfonic acid substituent with 1-10 carbon atoms, a fluorosulfonic acid substituent or an aromatic sulfonic acid substituent, and R3 is a protective group) is heated under stirring in an inert organic solvent in a presence of a phase transfer catalyst, 18F ions and potassium ions, so as to effect labeling with a radioactive fluorine, wherein the heating temperature is 40-90° C., and the concentration of the phase transfer catalyst in the inert organic solvent is 70 mmol/L or more. Preferably, the molar ratio of the phase transfer catalyst is 0.Type: GrantFiled: December 16, 2008Date of Patent: September 18, 2012Assignee: Nihon Medi-Physics Co., Ltd.Inventors: Fumie Kurosaki, Masahito Toyama, Akio Hayashi
-
Patent number: 8218945Abstract: A motion picture recording/reproducing apparatus for embodying the technique includes, at least, a motion picture data input unit which inputs the motion picture data, a storage unit which stores the motion picture data, a recording unit which stores the motion picture data in the storage unit, a feature generating unit which generates a feature of the motion picture data, a ranking generating unit which provides ranking of scenes in the motion picture data according to their importance levels, a reproduction scene deciding unit which decides a reproduction image for each of the scenes in the motion picture data, and a category acquiring unit which acquires the category of the motion picture data. The ranking generating unit provides ranking of the scenes in the input motion picture data on the basis of the acquired category.Type: GrantFiled: December 22, 2005Date of Patent: July 10, 2012Assignee: Hitachi, Ltd.Inventors: Kazushige Hiroi, Yoshifumi Fujikawa, Norikazu Sasaki, Riri Ueda, Akio Hayashi, Yukio Fujii, Atsuo Kawaguchi
-
Publication number: 20120142072Abstract: Disclosed is a method for screening a medicine using a protein, and a compound obtained by the screening method. A compound or a salt thereof inhibiting activity or expression of the protein of the present invention, a neutralizing antibody against the protein, a polynucleotide that are complementary to a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating neurodegenerative diseases and the like. Moreover, a compound or a salt thereof enhancing activity or expression of the protein of the present invention, the protein or a partial peptide thereof, a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating cancers and the like. Furthermore, the protein of the present invention is useful as a reagent for screening a compound inhibiting or enhancing activity of the protein.Type: ApplicationFiled: December 22, 2011Publication date: June 7, 2012Applicant: ONO PHARMACEUTICAL CO., LTD.Inventors: Hideaki Tada, Tomoyuki Bando, Akio Hayashi
-
Patent number: 8110660Abstract: The present invention relates to a method for screening a medicine using a protein, and a compound obtained by the screening method. A compound or a salt thereof inhibiting activity or expression of the protein of the present invention, a neutralizing antibody against the protein, a polynucleotide that are complementary to a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating neurodegenerative diseases and the like. Moreover, a compound or a salt thereof enhancing activity or expression of the protein of the present invention, the protein or a partial peptide thereof, a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating cancers and the like. Furthermore, the protein of the present invention is useful as a reagent for screening a compound inhibiting or enhancing activity of the protein.Type: GrantFiled: November 18, 2005Date of Patent: February 7, 2012Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Hideaki Tada, Tomoyuki Bando, Akio Hayashi
-
Publication number: 20110123550Abstract: A purpose of the present invention is to provide a method capable of more effectively prescribing an anti-human PD-1 antibody for anti-cancer therapy, a method for estimating or optimizing therapeutic efficacy thereof, and further an efficacy marker that can be used in methods thereof. The present invention enables selection of the cancer patient in whom the therapeutic efficacy of the anti-human PD-1 antibody can be expected in future, by measuring the change which is more than a certain level of several kinds of efficacy markers in blood after administering the initial dose or doses of the anti-human PD-1 antibody compared to that prior to administering the initial dose, and provides a new prescription of the anti-human PD-1 antibody for anti-cancer therapy.Type: ApplicationFiled: July 3, 2009Publication date: May 26, 2011Applicants: ONO PHARMACEUTICAL CO., LTD., MEDAREX, INC.Inventors: Shiro Shibayama, Takao Yoshida, Tamon Hayashi, Akio Hayashi, Jun Murai
-
Patent number: 7910745Abstract: It is intended to provide a labeling precursor compound used for selectively producing radioactive halogen-substituted syn-1-amino-3-cyclobutane-carboxylic acids, and to provide a process for producing a radioactive halogen-substituted syn-1-amino-3-cyclobutane-carboxylic acid using the labeling precursor compound. A labeling precursor is used in which a phthalimide group is used as a protective group for protecting the amino group. The syn-form of the radioactive halogen-substituted 1-amino-3-cyclobutane-carboxylic acid can be selectively produced by labeling the labeling precursor with a radioactive halogen followed by deprotecting.Type: GrantFiled: May 15, 2006Date of Patent: March 22, 2011Assignee: Nihon Medi-Physics Co., Ltd.Inventors: Masahito Toyama, Fumie Kurosaki, Akio Hayashi, Osamu Ito
-
Patent number: 7897811Abstract: A process is provided for producing [18F]FACBC, which can reduce the production amount of impurities.Type: GrantFiled: May 7, 2007Date of Patent: March 1, 2011Assignee: Nihon Medi-Physics Co., Ltd.Inventors: Akio Hayashi, Fumie Kurosaki, Masahito Toyama, Toshiyuki Shinmura, Emi Kaneko
-
Publication number: 20100329636Abstract: A video playback apparatus includes a first unit which inputs a viewing time of video data to be played back, a second unit which extracts scenes on a basis of a power of audio in the video data or a movement of image in the video data so that a sum of the time of the extracted playback scenes is within the viewing time, and a third unit which plays back the extracted scenes.Type: ApplicationFiled: September 13, 2010Publication date: December 30, 2010Inventors: Kazushige HIROI, Yoshifumi FUJIKAWA, Norikazu SASAKI, Riri UEDA, Akio HAYASHI, Yukio FUJII, Atsuo Kawaguchi
-
Publication number: 20100332524Abstract: In a destination search function, a narrow search function for displaying the number of hits and next candidates, when an index having data on the number of hits and the next candidate characters is held and a narrow search is speeded up referring to the index during a search. Only about a narrow search result in which the hit numbers is large such that a search time is elongated when referring to numbers, indexes in which the number of hits and next candidate characters as the narrow search result are computed are previously stored. At the time of performing the narrow search, when the number of hits is small and the numbers and the next candidates are not registered, the numbers is counted. When the number of hits and the next candidate characters are registered in the index, the narrow search results are computed by using its registration result.Type: ApplicationFiled: June 29, 2010Publication date: December 30, 2010Applicant: Clarion Co., Ltd.Inventors: Takayuki UCHIDA, Yukihiro Kawamata, Hiroto Sasaki, Osamu Tomobe, Akio Hayashi
-
Publication number: 20100261931Abstract: A process for production of a radioactive fluorine-labeled organic compound is provided which can improve the yield of radioactive fluorination. Provided is a process in which a compound represented by the following formula (1): (wherein R1 is a straight or branched alkyl chain with 1-10 carbon atoms or an aromatic substituent, R2 is a straight or branched haloalkylsulfonic acid substituent with 1-10 carbon atoms, a straight or branched alkylsulfonic acid substituent with 1-10 carbon atoms, a fluorosulfonic acid substituent or an aromatic sulfonic acid substituent, and R3 is a protective group) is heated under stirring in an inert organic solvent in a presence of a phase transfer catalyst, 18F ions and potassium ions, so as to effect labeling with a radioactive fluorine, wherein the heating temperature is 40-90° C., and the concentration of the phase transfer catalyst in the inert organic solvent is 70 mmol/L or more. Preferably, the molar ratio of the phase transfer catalyst is 0.Type: ApplicationFiled: December 16, 2008Publication date: October 14, 2010Applicant: NIHON MEDI-PHYSICS CO., LTD.Inventors: Fumie Kurosaki, Masahito Toyama, Akio Hayashi
-
Publication number: 20100240583Abstract: The present invention relates to a method for screening a medicine using a protein, and a compound obtained by the screening method. A compound or a salt thereof inhibiting activity or expression of the protein of the present invention, a neutralizing antibody against the protein, a polynucleotide that are complementary to a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating neurodegenerative diseases and the like. Moreover, a compound or a salt thereof enhancing activity or expression of the protein of the present invention, the protein or a partial peptide thereof, a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating cancers and the like. Furthermore, the protein of the present invention is useful as a reagent for screening a compound inhibiting or enhancing activity of the protein.Type: ApplicationFiled: November 18, 2005Publication date: September 23, 2010Applicant: ONO PHARMACEUTICAL CO., LTD.Inventors: Hideaki Tada, Tomoyuki Bando, Akio Hayashi
-
Patent number: 7796857Abstract: A video playback apparatus includes: video data inputting unit; a ranking data inputting/generating unit that inputs or generates ranking data where scenes in video data are ranked according to importance; a playback scene determination parameter inputting unit that inputs parameters when determining scenes to be played back according to importance; a playback scene determining unit that determines playback scenes based on ranking data and playback scene determination parameters; and a display unit that displays playback scenes. A viewing time of video data that the user desires and a maximum time width of each playback scene are inputted to the playback scene determination parameter inputting unit, and the playback scene determining unit cuts scenes so that the playback time of the playback scenes fits the maximum time width, and determines the playback scenes so that the sum of the playback time of the playback scenes fits within the viewing time.Type: GrantFiled: June 17, 2005Date of Patent: September 14, 2010Assignee: Hitachi, Ltd.Inventors: Kazushige Hiroi, Yoshifumi Fujikawa, Norikazu Sasaki, Riri Ueda, Akio Hayashi, Yukio Fujii, Atsuo Kawaguchi
-
Publication number: 20100119448Abstract: A method for producing a radioactive diagnostic imaging agent which contains a radioactive halogen-labeled amino acid compound as an effective ingredient and has a composition that can inhibit radiolysis of the effective ingredient, thereby further improving stability, is provided. Disclosed is a method for producing a radioactive diagnostic imaging agent, comprising a solution preparation step of preparing a solution containing a radioactive halogen-labeled amino acid compound, and a dilution step of diluting the solution containing the radioactive fluorine-labeled organic compound in order to adjust radioactive concentration thereof, which further comprises an acid addition step of adding an acid to the solution containing the radioactive fluorine-labeled organic compound, after the solution preparation step and before the dilution step, wherein the acid is added in the acid addition step in an amount sufficient to adjust the pH of the solution resulting from the dilution step to 2.0-5.Type: ApplicationFiled: February 12, 2008Publication date: May 13, 2010Inventors: Daisaku Nakamura, Soichi Nakamura, Masahito Toyama, Akio Hayashi
-
Patent number: 7700792Abstract: To provide a highly active LPA and a method of screening therewith. There is provided a method of screening a preventive and/or therapeutic substance for diseases in which LPA takes part, characterized in that a compound represented by any of formula (I), (II) and (III): [wherein the meaning of characters are described in the description] is used. The compounds obtained by the screening method or the screening kit of the present invention, their salts, their solvates and prodrugs thereof would modulate the binding of highly active LPA with LPA receptor in human and other mammals, so that they can be used as a preventive and/or therapeutic agent for diseases in which LPA takes part, for example, urinary diseases, central nervous diseases, inflammatory diseases, circulatory diseases, cancer, diabetes, immune system disorders and alimentary diseases.Type: GrantFiled: December 22, 2004Date of Patent: April 20, 2010Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Akio Hayashi, Shinji Nakade, Hidehiro Suzuki